Neu-120
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Neu-120, covering 2018-03-29 to 2018-03-29. Get the full timeline:
Most recent: Clinical Trial Update: Safety, Tolerability, PK and PD Study of Neu-120 in the Treatment of Levodopa-induced Dyskinesia [Phase 1, Phase 2]